Endpoint Health
Endpoint Health is pioneering a new category of precision medicine, focusing on delivering personalized therapies for patients with immune-mediated diseases. The company aims to improve patient outcomes by rewriting the traditional molecule-first drug development model into a patient-first approach, ensuring that treatments are tailored to individual biological needs.
Industries
N/A
Services
Precision therapeutics and companion diagnostic co-development
End-to-end development of targeted therapeutics alongside companion diagnostic assays to enable patient selection and personalized treatment strategies.
Clinical collaborations and data access partnerships
Establishing and managing collaborations with health systems and clinical registries to secure clinical cohorts, real-world datasets and sites for research and clinical studies.
Data science and predictive analytics services
Development and application of predictive models and analytical pipelines to analyze clinical and molecular data for treatment-response prediction and retrospective cohort analyses.
Partnering and licensing
Negotiation and execution of strategic collaborations, licensing and commercialization agreements with industry partners to advance programs into broader development or commercialization pathways.
Precision therapeutics and companion diagnostic co-development
End-to-end development of targeted therapeutics alongside companion diagnostic assays to enable patient selection and personalized treatment strategies.
Clinical collaborations and data access partnerships
Establishing and managing collaborations with health systems and clinical registries to secure clinical cohorts, real-world datasets and sites for research and clinical studies.
Data science and predictive analytics services
Development and application of predictive models and analytical pipelines to analyze clinical and molecular data for treatment-response prediction and retrospective cohort analyses.
Partnering and licensing
Negotiation and execution of strategic collaborations, licensing and commercialization agreements with industry partners to advance programs into broader development or commercialization pathways.
Expertise Areas
- Precision immunology
- Companion diagnostic development
- Data-driven patient stratification
- Clinical trial operations and multi-site collaboration
Key Technologies
- Gene expression profiling
- Predictive modeling / machine learning for clinical outcomes
- Companion diagnostic assays (IVD)
- Clinical data registries and real-world data analytics